Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica

Target groups for human papillomavirus (HPV) vaccination are controversial. We evaluated vaccine efficacy (VE) against 1-year persistent infection, stratified by age and sexual behavior, among young women in Costa Rica. We randomized 7,466 healthy women 18 to 25 years of age to HPV16/18 or hepatitis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Herrero, Rolando, Wacholder, Sholom, Rodríguez, Ana C., Solomon, Diane, González, Paula, Kreimer, Aimee R., Porras, Carolina, Schussler, John, Jiménez, Silvia, Sherman, Mark E., Quint, Wim, Schiller, John T., Lowy, Douglas R., Schiffman, Mark, Hildesheim, Allan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354733/
https://ncbi.nlm.nih.gov/pubmed/22586631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0131
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak